We are an award-winning formulation development CDMO. We turn badly behaved molecules into smart formulations which give them the best chance of success in preclinical studies, and enable them to be accelerated to clinic and commercial.

Our core expertise is in developing formulations for small molecules, peptides and proteins for a range of routes of administration including oral, ocular, IV, intranasal and topical.

We develop and manufacture formulations to meet the needs of our clients including:
- Overcoming solubility and permeability issues
- Targeted drug delivery, including across the blood-brain barrier
- Lipid nanoparticle and liposomal formulations
- Immediate, controlled and sustained release
- Formulations and analytical methods suitable for preclinical safety and efficacy studies, including GLP tox studies
- Clinical and commercial prototypes
- Reverse engineering of existing products

Presentation Title:

View company profile